Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
Defense Tech and IPOs: Marlinspike CEO Neil Keegan, Live from NYSE
IPO Edge hosted a fireside chat on Feb. 13 from the floor of the New...
Nuclear-Powered Profits: Mirion CEO Tom Logan, Live at NYSE
IPO Edge hosted a fireside chat on Feb. 13 from the floor of the New...
One Power CEO Puts His Money Where His Mouth Is in IPO
By John Jannarone One Power Co. CEO and Founder Jereme Kent is so confident in...
The C-Suite View: Interview Highlights From ICR Conference 2025
IPO Edge, Exec Edge and CorpGov were live from the 27th annual ICR Conference held...
Twin Hospitality Group CEO Joe Hummel on Seasonal Sports Effect: ICR Conference 2025
IPO Edge hosted a fireside chat at the ICR Conference 2025 with Joe Hummel, Chief...
Arc’teryx CEO Stuart Haselden on Innovation: ICR Conference 2025
IPO Edge hosted a fireside chat at the ICR Conference 2025 with Stuart Haselden, Chief...
NYSE’s Tad Nacheff on IPO & Private Equity Outlook: ICR Conference 2025
IPO Edge hosted a fireside chat at the ICR Conference 2025 with Tad Nacheff, Head...
